SCHEMBL7965037

SCHEMBL7965037

Cc1cnc2[nH]cc(CN(C)C)c2c1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 14/20 0.44
CYP2C9 P11712 8/20 0.44
CYP2C19 P33261 6/20 0.44
CYP2D6 P10635 2/20 0.44
CYP1A2 P05177 1/20 0.44
KDM4E B2RXH2 1/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42
TSHR P16473 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
MAP4K1 Q92918 1/20 0.40
KIT P10721 2/20 0.39
KDR P35968 2/20 0.39
FLT3 P36888 2/20 0.39
AURKC Q9UQB9 2/20 0.39
CSF1R P07333 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30566012 0.84 HTR6 (0.48) CYP3A4CYP2C9CYP2C19CYP2D6CYP1A2
SCHEMBL25246536 0.84 HTR6 (0.48) CYP3A4CYP2C9CYP2C19CYP2D6CYP1A2
SCHEMBL30275071 0.83 CYP2D6 (0.43) CYP3A4CYP2C9CYP2C19CYP2D6CYP1A2
SCHEMBL14197017 0.83 CYP2D6 (0.43) CYP3A4CYP2C19CYP2D6CYP1A2KDM4E
SCHEMBL857144 0.83 AURKA (0.47) CYP3A4CYP2C19CYP2D6CYP1A2KDM4E
SCHEMBL30068918 0.83 AURKA (0.47) CYP3A4CYP2C19CYP2D6CYP1A2KDM4E
SCHEMBL1267965 0.83 JAK2 (0.47) CYP3A4CYP2C9CYP2C19CYP2D6CYP1A2
SCHEMBL12146866 0.81 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19MAP4K1KIT
Iodide SCHEMBL25299428 0.81 AURKA (0.46) CYP3A4CYP2C19CYP2D6CYP1A2KDM4E
Iodide SCHEMBL30068502 0.81 AURKA (0.46) CYP3A4CYP2C19CYP2D6CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100249118-A1 protein kinase modulators such as Propane-1-sulfonic acid [2,4-difluoro-3-(5-ethoxy-1H-pyrrolo[1,3-b]pyridine-3-carbonyl)-phenyl]-amide, used to regulate signal transduction cascades, involved in the control of physiological functions including cellular growth and proliferation; anticarcinogenic agents PLEXXIKON INC. 2010-09-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100249118-A1 protein kinase modulators such as Propane-1-sulfonic acid [2,4-difluoro-3-(5-ethoxy-1H-pyrrolo[1,3-b]pyridine-3-carbonyl)-phenyl]-amide, used to regulate signal transduction cascades, involved in the control of physiological functions including cellular growth and proliferation; anticarcinogenic agents MAP4K1, MAP4K2, MAP3K1 CYP3A4 4851/4885CYP2C9 4869/4885CYP2C19 4868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.